Fisher Scientific to Divest Atos Medical AB

10-Mar-2005

Fisher Scientific International Inc. announced that it has signed a definitive agreement to sell Atos Medical AB, a manufacturer of ear, nose and throat medical devices with 2004 sales totaling $35 million, to Nordic Capital for $110 million in cash.

Acquired by Fisher in its 2003 transaction with Perbio Science AB, Sweden-based Atos Medical is the world leader in providing devices designed to rehabilitate the voice and pulmonary functions after laryngectomy for the treatment of cancer. Atos also provides other devices for the treatment of ear and sinus diseases.

The transaction is subject to customary closing conditions. Fisher expects to complete the transaction by the beginning of the second quarter.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances